Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Ileus as a Sign of Neuroleptic Malignant Syndrome: A Case Report and Review of the Literature

Forouzan Elyasi 1 , 2 , * , Marzieh Azizi 3 , 4 , Mahboobeh Shirzad 5 , Roya Ghasemian 6 , Arash Kazemi 5 and Sabahat Lavvaf 7
Authors Information
1 Department of Psychiatry, Collage of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
2 Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, IR Iran
3 Nasibeh Nursing and Midwifery Faculty, Sari, IR Iran
4 Student Research Committee, Mazandaran University of Medical Sciences, Sari, IR Iran
5 Gut and Liver Research Center, Department of Internal Medicine, Collage of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
6 Antimicrobial Resistance Research Center, Department of Infectious Disease, Collage of Medicine, Mazandaran University of Medical Sciences, Sari, IR Iran
7 Student Research Committee, Mazandaran University of Medical Sciences, Sari, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: September 2018, 12 (3); e9844
  • Published Online: July 21, 2018
  • Article Type: Case Report
  • Received: November 28, 2016
  • Revised: April 28, 2017
  • Accepted: November 22, 2017
  • DOI: 10.5812/ijpbs.9844

To Cite: Elyasi F, Azizi M, Shirzad M, Ghasemian R, Kazemi A, et al. Ileus as a Sign of Neuroleptic Malignant Syndrome: A Case Report and Review of the Literature, Iran J Psychiatry Behav Sci. 2018 ; 12(3):e9844. doi: 10.5812/ijpbs.9844.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Demir MV, Demir TO, Yaylaci S, Yildiz H, Tayci I, Baydar M. Neuroleptic malignant syndrome induced by concomitant use of risperidone and quetiapine. CHRISMED J Health Res. 2016;3(2):141. doi: 10.4103/2348-3334.177643.
  • 2. Shalev A, Munitz H. The neuroleptic malignant syndrome: agent and host interaction. Acta Psychiatr Scand. 1986;73(4):337-47. [PubMed: 2873715].
  • 3. Sajatovic M, Munshi KR; Adityanjee. Neuropsychiatric sequelae of neuroleptic malignant syndrome. Clin Neuropharmacol. 2005;28(4):197-204. [PubMed: 16062103].
  • 4. Addonizio G, Susman VL, Roth SD. Neuroleptic malignant syndrome: review and analysis of 115 cases. Biol Psychiatry. 1987;22(8):1004-20. [PubMed: 2886157].
  • 5. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65(4):464-70. [PubMed: 15119907].
  • 6. Caroff SN, Mann SC, Campbell EC. Atypical Antipsychotics and Neuroleptic Malignant Syndrome. Psychiatric Annals. 2000;30(5):314-21. doi: 10.3928/0048-5713-20000501-09.
  • 7. Farver DK. Neuroleptic malignant syndrome induced by atypical antipsychotics. Expert Opin Drug Saf. 2005;2(1):21-35. doi: 10.1517/14740338.2.1.21.
  • 8. Belvederi Murri M, Guaglianone A, Bugliani M, Calcagno P, Respino M, Serafini G, et al. Second-generation antipsychotics and neuroleptic malignant syndrome: systematic review and case report analysis. Drugs R D. 2015;15(1):45-62. doi: 10.1007/s40268-014-0078-0. [PubMed: 25578944]. [PubMed Central: PMC4359181].
  • 9. Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23(6):477-92. doi: 10.2165/00023210-200923060-00003. [PubMed: 19480467].
  • 10. Trollor JN, Chen X, Chitty K, Sachdev PS. Comparison of neuroleptic malignant syndrome induced by first- and second-generation antipsychotics. Br J Psychiatry. 2012;201(1):52-6. doi: 10.1192/bjp.bp.111.105189. [PubMed: 22626633].
  • 11. Verdoux H, Tournier M, Begaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010;121(1):4-10. doi: 10.1111/j.1600-0447.2009.01425.x. [PubMed: 20059452].
  • 12. Chen Y, Guo JJ, Steinbuch M, Buckley PF, Patel NC. Risk of neuroleptic malignant syndrome in patients with bipolar disorder: a retrospective, population-based case-control study. Int J Psychiatry Med. 2009;39(4):439-50. doi: 10.2190/PM.39.4.h. [PubMed: 20391864].
  • 13. Su YP, Chang CK, Hayes RD, Harrison S, Lee W, Broadbent M, et al. Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome. Acta Psychiatr Scand. 2014;130(1):52-60. doi: 10.1111/acps.12222. [PubMed: 24237642].
  • 14. Strawn JR, Keck PEJ, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870-6. doi: 10.1176/ajp.2007.164.6.870. [PubMed: 17541044].
  • 15. Gurrera RJ, Mortillaro G, Velamoor V, Caroff SN. A Validation Study of the International Consensus Diagnostic Criteria for Neuroleptic Malignant Syndrome. J Clin Psychopharmacol. 2017;37(1):67-71. doi: 10.1097/JCP.0000000000000640. [PubMed: 28027111].
  • 16. Odagaki Y. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics? Curr Drug Saf. 2009;4(1):84-93. [PubMed: 19149529].
  • 17. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of Newer Antipsychotics on Extrapyramidal Function. CNS Drugs. 2002;16(1):23-45. doi: 10.2165/00023210-200216010-00003.
  • 18. Monte AA, Waksman JC. Chronic olanzapine, serotonin receptors, and subsequent serotonin toxicity. J Clin Psychopharmacol. 2010;30(5):628-9. doi: 10.1097/JCP.0b013e3181ef09f8. [PubMed: 20841960].
  • 19. Marlowe K, Schirgel D. Quetiapine and citalopram: aetiological significances in serotonin syndrome. N Z Med J. 2006;119(1237):U2058. [PubMed: 16862204].
  • 20. Buckley PF, Hasan S. Atypical neuroleptic malignant syndrome and atypical antipsychotics. Am J Psychiatry. 1998;155(11):1633. [PubMed: 9812143].
  • 21. Tollefson G. A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia. J Clin Psychopharmacol. 1982;2(4):266-70. [PubMed: 6126494].
  • 22. Allsop P, Twigley AJ. The neuroleptic malignant syndrome. Anaesthesia. 1987;42(1):49-53. doi: 10.1111/j.1365-2044.1987.tb02944.x.
  • 23. Harsch HH. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. J Clin Psychiatry. 1987;48(8):328-33. [PubMed: 2886491].
  • 24. Dudley HA, Paterson-Brown S. Pseudo-obstruction. Br Med J (Clin Res Ed). 1986;292(6529):1157-8. [PubMed: 3085764]. [PubMed Central: PMC1340174].
  • 25. Stephens FO. Syndrome of Intestinal Pseudo-obstruction. Br Med J. 1962;1(5287):1248-1238 2. [PubMed: 20789407]. [PubMed Central: PMC1958538].
  • 26. Tsung SH. Creatine kinase isoenzyme patterns in human tissue obtained at surgery. Clin Chem. 1976;22(2):173-5. [PubMed: 1248117].
  • 27. Roberts R, Sobel BE. Creatine kinase isoenzymes in the assessment of heart disease. Am Heart J. 1978;95(4):521-8. [PubMed: 345787].
  • 28. Henry PD, Roberts R, Sobel BE. Rapid separation of plasma creatine kinase isoenzymes by batch adsorption on glass beads. Clin Chem. 1975;21(7):844-9. [PubMed: 1132135].
  • 29. Baldessarini RJ, Marsh E. Fluoxetine and side effects. Arch Gen Psychiatry. 1990;47(2):191-2. [PubMed: 2105706].
  • 30. Lindvall O, Bjorklund A, Skagerberg G. Dopamine-containing neurons in the spinal cord: anatomy and some functional aspects. Ann Neurol. 1983;14(3):255-60. doi: 10.1002/ana.410140302. [PubMed: 6314870].
  • 31. Tanaka O, Otani K, Kondo T, Kaneko S, Fukushima Y. Paralytic ileus as a prodromal symptom of the neuroleptic malignant syndrome. Hum Psychopharm Clin. 1993;8(5):367-9. doi: 10.1002/hup.470080511.
  • 32. Lo TC, Unwin MR, Dymock IW. Neuroleptic malignant syndrome: another medical cause of acute abdomen. Postgrad Med J. 1989;65(767):653-5. [PubMed: 2608597]. [PubMed Central: PMC2429179].
  • 33. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv. 1998;49(9):1163-72. doi: 10.1176/ps.49.9.1163. [PubMed: 9735957].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments